211 related articles for article (PubMed ID: 18344973)
1. Lentivector-mediated rescue from cerebellar ataxia in a mouse model of spinocerebellar ataxia.
Torashima T; Koyama C; Iizuka A; Mitsumura K; Takayama K; Yanagi S; Oue M; Yamaguchi H; Hirai H
EMBO Rep; 2008 Apr; 9(4):393-9. PubMed ID: 18344973
[TBL] [Abstract][Full Text] [Related]
2. CRMP5-associated GTPase (CRAG) protein protects neuronal cells against cytotoxicity of expanded polyglutamine protein partially via c-Fos-dependent activator protein-1 activation.
Nagashima S; Fukuda T; Kubota Y; Sugiura A; Nakao M; Inatome R; Yanagi S
J Biol Chem; 2011 Sep; 286(39):33879-89. PubMed ID: 21832068
[TBL] [Abstract][Full Text] [Related]
3. A novel GTPase, CRAG, mediates promyelocytic leukemia protein-associated nuclear body formation and degradation of expanded polyglutamine protein.
Qin Q; Inatome R; Hotta A; Kojima M; Yamamura H; Hirai H; Yoshizawa T; Tanaka H; Fukami K; Yanagi S
J Cell Biol; 2006 Feb; 172(4):497-504. PubMed ID: 16461359
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional dysregulation of TrkA associates with neurodegeneration in spinocerebellar ataxia type 17.
Shah AG; Friedman MJ; Huang S; Roberts M; Li XJ; Li S
Hum Mol Genet; 2009 Nov; 18(21):4141-52. PubMed ID: 19643914
[TBL] [Abstract][Full Text] [Related]
5. Reduced brain-derived neurotrophic factor (BDNF) mRNA expression and presence of BDNF-immunoreactive granules in the spinocerebellar ataxia type 6 (SCA6) cerebellum.
Takahashi M; Ishikawa K; Sato N; Obayashi M; Niimi Y; Ishiguro T; Yamada M; Toyoshima Y; Takahashi H; Kato T; Takao M; Murayama S; Mori O; Eishi Y; Mizusawa H
Neuropathology; 2012 Dec; 32(6):595-603. PubMed ID: 22393909
[TBL] [Abstract][Full Text] [Related]
6. Delayed spinocerebellar ataxia in transgenic mice expressing mutant ubiquitin.
Tsirigotis M; Tang MY; Beyers M; Zhang M; Woulfe J; Gray DA
Neuropathol Appl Neurobiol; 2006 Feb; 32(1):26-39. PubMed ID: 16409551
[TBL] [Abstract][Full Text] [Related]
7. An miRNA-mediated therapy for SCA6 blocks IRES-driven translation of the CACNA1A second cistron.
Miyazaki Y; Du X; Muramatsu S; Gomez CM
Sci Transl Med; 2016 Jul; 8(347):347ra94. PubMed ID: 27412786
[TBL] [Abstract][Full Text] [Related]
8. Purkinje cell COX deficiency and mtDNA depletion in an animal model of spinocerebellar ataxia type 1.
Ripolone M; Lucchini V; Ronchi D; Fagiolari G; Bordoni A; Fortunato F; Mondello S; Bonato S; Meregalli M; Torrente Y; Corti S; Comi GP; Moggio M; Sciacco M
J Neurosci Res; 2018 Sep; 96(9):1576-1585. PubMed ID: 30113722
[TBL] [Abstract][Full Text] [Related]
9. Basic research on cerebellar gene therapy using lentiviral vectors.
Hirai H
Cerebellum; 2012 Jun; 11(2):443-5. PubMed ID: 22120847
[TBL] [Abstract][Full Text] [Related]
10. The carboxy-terminal fragment of alpha(1A) calcium channel preferentially aggregates in the cytoplasm of human spinocerebellar ataxia type 6 Purkinje cells.
Ishiguro T; Ishikawa K; Takahashi M; Obayashi M; Amino T; Sato N; Sakamoto M; Fujigasaki H; Tsuruta F; Dolmetsch R; Arai T; Sasaki H; Nagashima K; Kato T; Yamada M; Takahashi H; Hashizume Y; Mizusawa H
Acta Neuropathol; 2010 Apr; 119(4):447-64. PubMed ID: 20043227
[TBL] [Abstract][Full Text] [Related]
11. Spinocerebellar ataxia type 1--modeling the pathogenesis of a polyglutamine neurodegenerative disorder in transgenic mice.
Clark HB; Orr HT
J Neuropathol Exp Neurol; 2000 Apr; 59(4):265-70. PubMed ID: 10759181
[TBL] [Abstract][Full Text] [Related]
12. Cerebellum-enriched protein INPP5A contributes to selective neuropathology in mouse model of spinocerebellar ataxias type 17.
Liu Q; Huang S; Yin P; Yang S; Zhang J; Jing L; Cheng S; Tang B; Li XJ; Pan Y; Li S
Nat Commun; 2020 Feb; 11(1):1101. PubMed ID: 32107387
[TBL] [Abstract][Full Text] [Related]
13. Computational analysis of calcium signaling and membrane electrophysiology in cerebellar Purkinje neurons associated with ataxia.
Brown SA; Loew LM
BMC Syst Biol; 2012 Jun; 6():70. PubMed ID: 22703638
[TBL] [Abstract][Full Text] [Related]
14. Relationship between ataxin-1 nuclear inclusions and Purkinje cell specific proteins in SCA-1 transgenic mice.
Vig PJ; Subramony SH; Qin Z; McDaniel DO; Fratkin JD
J Neurol Sci; 2000 Mar; 174(2):100-10. PubMed ID: 10727695
[TBL] [Abstract][Full Text] [Related]
15. Post-symptomatic Delivery of Brain-Derived Neurotrophic Factor (BDNF) Ameliorates Spinocerebellar Ataxia Type 1 (SCA1) Pathogenesis.
Sheeler C; Rosa JG; Borgenheimer E; Mellesmoen A; Rainwater O; Cvetanovic M
Cerebellum; 2021 Jun; 20(3):420-429. PubMed ID: 33394333
[TBL] [Abstract][Full Text] [Related]
16. Broad distribution of ataxin 1 silencing in rhesus cerebella for spinocerebellar ataxia type 1 therapy.
Keiser MS; Kordower JH; Gonzalez-Alegre P; Davidson BL
Brain; 2015 Dec; 138(Pt 12):3555-66. PubMed ID: 26490326
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cell transplantation ameliorates motor function deterioration of spinocerebellar ataxia by rescuing cerebellar Purkinje cells.
Chang YK; Chen MH; Chiang YH; Chen YF; Ma WH; Tseng CY; Soong BW; Ho JH; Lee OK
J Biomed Sci; 2011 Aug; 18(1):54. PubMed ID: 21824437
[TBL] [Abstract][Full Text] [Related]
18. A New Mouse Model Related to SCA14 Carrying a Pseudosubstrate Domain Mutation in PKCĪ³ Shows Perturbed Purkinje Cell Maturation and Ataxic Motor Behavior.
Shimobayashi E; Kapfhammer JP
J Neurosci; 2021 Mar; 41(9):2053-2068. PubMed ID: 33478986
[TBL] [Abstract][Full Text] [Related]
19. One-year follow-up of transgene expression by integrase-defective lentiviral vectors and their therapeutic potential in spinocerebellar ataxia model mice.
Saida H; Matsuzaki Y; Takayama K; Iizuka A; Konno A; Yanagi S; Hirai H
Gene Ther; 2014 Sep; 21(9):820-7. PubMed ID: 24989813
[TBL] [Abstract][Full Text] [Related]
20. Antisense oligonucleotide therapy for spinocerebellar ataxia type 2.
Scoles DR; Meera P; Schneider MD; Paul S; Dansithong W; Figueroa KP; Hung G; Rigo F; Bennett CF; Otis TS; Pulst SM
Nature; 2017 Apr; 544(7650):362-366. PubMed ID: 28405024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
